Collegium Pharma (COLL) Reports Q1 Loss of $1.05/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. CVS
9. SPY
10. XYZ

Go back to Collegium Pharma (COLL) Reports Q1 Loss of $1.05/Share

Collegium Reports Second Quarter Financial Results and Provides Corporate Update

August 10, 2016 4:01 PM EDT

Received FDA approval for Xtampza® ER, Companys lead opioid analgesic with abuse-deterrent propertiesAnnounced U.S. commercial launch of Xtampza ER Reported positive results from a clinical study comparing effect of physical manipulation of Xtampza ER with the abuse-deterrent version of OxyContin®Reported positive results from a clinical study evaluating Hydrocodone DETERx® as a second product candidateLicensed U.S. rights to commercialize ONSOLIS® (fentanyl buccal soluble film) from BioDelivery Sciences International

CANTON, Mass., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq:... More